Works matching AU SALLES, GILLES

Results: 193
    1

    Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01321-w
    By:
    • Einarsdottir, Sigrun;
    • Lobaugh, Stephanie;
    • Luan, Danny;
    • Gomez-Llobell, Marina;
    • Subramanian, Padmapriya;
    • Devlin, Sean;
    • Chung, David;
    • Dahi, Parastoo B.;
    • Falchi, Lorenzo;
    • Giralt, Sergio;
    • Landau, Heather;
    • Lesokhin, Alexander M.;
    • Lin, Richard;
    • Lue, Jennifer;
    • Mailankody, Sham;
    • Palomba, M. Lia;
    • Park, Jae H.;
    • Salles, Gilles;
    • Scordo, Michael;
    • Escribano-Serrat, Silvia
    Publication type:
    Article
    2
    3

    Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe.

    Published in:
    EJHaem, 2023, v. 4, n. 1, p. 45, doi. 10.1002/jha2.593
    By:
    • Bishton, Mark J.;
    • Salles, Gilles;
    • Golfier, Camille;
    • Knauf, Wolfgang;
    • Bocchia, Monica;
    • Turner, Deborah;
    • Slama, Borhane;
    • Harchowal, Jatinder;
    • Marshall, Scott;
    • Bosi, Alberto;
    • Lleonart, Juan José Bargay;
    • Welslau, Manfred;
    • Kim, SooKyoung;
    • Lee, Young N.;
    • Zinzani, Pier L.;
    • Laribi, Kamel
    Publication type:
    Article
    4
    5

    Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management.

    Published in:
    Viruses (1999-4915), 2018, v. 10, n. 11, p. 633, doi. 10.3390/v10110633
    By:
    • Bal, Antonin;
    • Sarkozy, Clémentine;
    • Josset, Laurence;
    • Cheynet, Valérie;
    • Oriol, Guy;
    • Becker, Jérémie;
    • Vilchez, Gaëlle;
    • Sesques, Pierre;
    • Mallet, François;
    • Pachot, Alexandre;
    • Morfin, Florence;
    • Lina, Bruno;
    • Salles, Gilles;
    • Reynier, Fréderic;
    • Trouillet-Assant, Sophie;
    • Brengel-Pesce, Karen
    Publication type:
    Article
    6
    7
    8
    9
    10

    Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 5, p. 1938, doi. 10.1007/s12325-024-02822-z
    By:
    • Salles, Gilles;
    • Chen, Jenny M. H.;
    • Zhang, Ina;
    • Kerbauy, Fabio;
    • Wu, James J.;
    • Wade, Sally W.;
    • Nunes, Ana;
    • Feng, Chaoling;
    • Kloos, Ioana;
    • Peng, Weimin;
    • Snider, Julia T.;
    • Maciel, Dylan;
    • Chan, Keith;
    • Keeping, Sam;
    • Shah, Bijal
    Publication type:
    Article
    11
    12
    13

    Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2--Technical).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 239, doi. 10.2967/jnumed.122.264124
    By:
    • Ricard, Fabien;
    • Barrington, Sally;
    • Korn, Ron;
    • Brueggenwerth, Guenther;
    • Trotman, Judith;
    • Cheson, Bruce;
    • Salles, Gilles;
    • Schwartz, Larry;
    • Goldmacher, Greg;
    • Jarecha, Rudresh;
    • Narang, Jayant;
    • Broussais, Florence;
    • Galette, Paul;
    • Min Liu;
    • Bajpai, Surabhi;
    • Perlman, Eric;
    • Gillis, Julie;
    • Smalberg, Ira;
    • Terve, Pierre;
    • Zahlmann, Gudrun
    Publication type:
    Article
    14

    Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1--Clinical).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 102, doi. 10.2967/jnumed.122.264106
    By:
    • Ricard, Fabien;
    • Cheson, Bruce;
    • Barrington, Sally;
    • Trotman, Judith;
    • Schmid, Annette;
    • Brueggenwerth, Guenther;
    • Salles, Gilles;
    • Schwartz, Larry;
    • Goldmacher, Greg;
    • Jarecha, Rudresh;
    • Narang, Jayant;
    • Broussais, Florence;
    • Galette, Paul;
    • Min Liu;
    • Bajpai, Surabhi;
    • Perlman, Eric;
    • Gillis, Julie;
    • Smalberg, Ira;
    • Terve, Pierre;
    • Zahlmann, Gudrun
    Publication type:
    Article
    15

    APPLICATION OF THE LUGANO CLASSIFICATION FOR INITIAL EVALUATION, STAGING, AND RESPONSE ASSESSMENT OF HODGKIN AND NON-HODGKIN LYMPHOMA: THE PROLOG CONSENSUS INITIATIVE (PART 1- CLINICAL).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264106
    By:
    • Ricard, Fabien;
    • Cheson, Bruce;
    • Barrington, Sally;
    • Trotman, Judith;
    • Schmid, Annette;
    • Brueggenwerth, Guenther;
    • Salles, Gilles;
    • Schwartz, Larry;
    • Goldmacher, Greg;
    • Jarecha, Rudresh;
    • Narang, Jayant;
    • Broussais, Florence;
    • Galette, Paul;
    • Liu, Min;
    • Bajpai, Surabhi;
    • Perlman, Eric;
    • Gillis, Julie;
    • Smalberg, Ira;
    • Terve, Pierre;
    • Zahlmann, Gudrun
    Publication type:
    Article
    16

    APPLICATION OF THE LUGANO CLASSIFICATION FOR INITIAL EVALUATION, STAGING, AND RESPONSE ASSESSMENT OF HODGKIN AND NON-HODGKIN LYMPHOMA: THE PROLOG CONSENSUS INITIATIVE (PART 2- TECHNICAL).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264124
    By:
    • Ricard, Fabien;
    • Barrington, Sally;
    • Korn, Ron;
    • Brueggenwerth, Guenther;
    • Trotman, Judith;
    • Cheson, Bruce;
    • Salles, Gilles;
    • Schwartz, Larry;
    • Goldmacher, Greg;
    • Jarecha, Rudresh;
    • Narang, Jayant;
    • Broussais, Florence;
    • Galette, Paul;
    • Min Liu;
    • Bajpai, Surabhi;
    • Perlman, Eric;
    • Gillis, Julie;
    • Smalberg, Ira;
    • Terve, Pierre;
    • Zahlmann, Gudrun
    Publication type:
    Article
    17

    APPLICATION OF THE LUGANO CLASSIFICATION FOR INITIAL EVALUATION, STAGING, AND RESPONSE ASSESSMENT OF HODGKIN AND NON-HODGKIN LYMPHOMA: THE PROLOG CONSENSUS INITIATIVE (PART 1- CLINICAL).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264106
    By:
    • Ricard, Fabien;
    • Cheson, Bruce;
    • Barrington, Sally;
    • Trotman, Judith;
    • Schmid, Annette;
    • Brueggenwerth, Guenther;
    • Salles, Gilles;
    • Schwartz, Larry;
    • Goldmacher, Greg;
    • Jarecha, Rudresh;
    • Narang, Jayant;
    • Broussais, Florence;
    • Galette, Paul;
    • Min Liu;
    • Bajpai, Surabhi;
    • Perlman, Eric;
    • Gillis, Julie;
    • Smalberg, Ira;
    • Terve, Pierre;
    • Zahlmann, Gudrun
    Publication type:
    Article
    18

    Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.

    Published in:
    International Journal of Environmental Research & Public Health, 2020, v. 17, n. 5, p. 1783, doi. 10.3390/ijerph17051783
    By:
    • Relecom, Allan;
    • Federico, Massimo;
    • Connors, Joseph M.;
    • Coiffier, Bertrand;
    • Biasoli, Irene;
    • Moccia, Alden;
    • Salles, Gilles;
    • McKee, Thomas;
    • Miralbell, Raymond;
    • Borchmann, Peter;
    • Kuruvilla, John;
    • Johnson, Peter;
    • Cavalli, Franco;
    • Delavy, Martine;
    • Dietrich, Pierre-Yves;
    • Flahault, Antoine
    Publication type:
    Article
    19

    Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. 48, doi. 10.1002/ajh.27137
    By:
    • Ghergus, Dana;
    • Martin, Mickaël;
    • Knapp, Anne‐Marie;
    • Delmotte, Fabien;
    • Joublin‐Delavat, Aurélie;
    • Jung, Sophie;
    • Schickel, Jean‐Nicolas;
    • Mendel, Isabelle;
    • Dupuis, Arnaud;
    • Drénou, Bernard;
    • Ghesquières, Hervé;
    • Salles, Gilles;
    • Baseggio, Lucile;
    • Herbrecht, Raoul;
    • Korganow, Anne‐Sophie;
    • Vallat, Laurent;
    • Soulas‐Sprauel, Pauline;
    • Meffre, Eric;
    • Martin, Thierry
    Publication type:
    Article
    20
    21

    Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. 599, doi. 10.1002/ajh.26149
    By:
    • Maurer, Matthew J.;
    • Jakobsen, Lasse H.;
    • Mwangi, Raphael;
    • Schmitz, Norbert;
    • Farooq, Umar;
    • Flowers, Cristopher R.;
    • Nully Brown, Peter;
    • Thompson, Carrie A.;
    • Frederiksen, Henrik;
    • Cunningham, David;
    • Jørgensen, Judit;
    • Poeschel, Viola;
    • Nowakowski, Grzegorz;
    • Seymour, John F.;
    • Merli, Francesco;
    • Haioun, Corinne;
    • Ghesquieres, Hervé;
    • Ziepert, Marita;
    • Tilly, Hervé;
    • Salles, Gilles
    Publication type:
    Article
    22

    Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 5, p. 510, doi. 10.1002/ajh.25757
    By:
    • Timmerman, John;
    • Herbaux, Charles;
    • Ribrag, Vincent;
    • Zelenetz, Andrew D.;
    • Houot, Roch;
    • Neelapu, Sattva S.;
    • Logan, Theodore;
    • Lossos, Izidore S.;
    • Urba, Walter;
    • Salles, Gilles;
    • Ramchandren, Radhakrishnan;
    • Jacobson, Caron;
    • Godwin, John;
    • Carpio, Cecilia;
    • Lathers, Deanne;
    • Liu, Yali;
    • Neely, Jaclyn;
    • Suryawanshi, Satyendra;
    • Koguchi, Yoshinobu;
    • Levy, Ronald
    Publication type:
    Article
    23

    Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 12, p. 1314, doi. 10.1002/ajh.25632
    By:
    • Deshayes, Samuel;
    • Khellaf, Mehdi;
    • Zarour, Anissa;
    • Layese, Richard;
    • Fain, Olivier;
    • Terriou, Louis;
    • Viallard, Jean‐François;
    • Cheze, Stéphane;
    • Graveleau, Julie;
    • Slama, Borhane;
    • Audia, Sylvain;
    • Cliquennois, Manuel;
    • Ebbo, Mikael;
    • Le Guenno, Guillaume;
    • Salles, Gilles;
    • Bonmati, Caroline;
    • Teillet, France;
    • Galicier, Lionel;
    • Lambotte, Olivier;
    • Hot, Arnaud
    Publication type:
    Article
    24
    25

    Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 1, p. E24, doi. 10.1002/ajh.24951
    By:
    • Guillermin, Yann;
    • Herbaux, Charles;
    • Subtil, Fabien;
    • Aurran‐Schleinitz, Thérèse;
    • Cymbalista, Florence;
    • Letestu, Remi;
    • Leprêtre, Stéphane;
    • Vaudaux, Sandrine;
    • Laribi, Kamel;
    • Leblond, Véronique;
    • Defoi, Yasmina;
    • Benchikh, Raouf;
    • Salles, Gilles;
    • Godmer, Pascal;
    • Jardel, Henry;
    • Vallais, Fréderic;
    • Feugier, Pierre;
    • Orsini, Frédérique;
    • Pegourié, Brigitte;
    • Lévy, Vincent
    Publication type:
    Article
    26
    27

    Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

    Published in:
    American Journal of Hematology, 2016, v. 91, p. 410, doi. 10.1002/ajh.24305
    By:
    • Bachy, Emmanuel;
    • Estell, Jane A.;
    • Van de Neste, Eric;
    • Bouabdallah, Réda;
    • Bargay, Joan;
    • Delmer, Alain;
    • Gelas-Dore, Bénédicte;
    • Gomes da Silva, Maria;
    • Fitoussi, Olivier;
    • Belada, David;
    • Maisonneuve, Hervé;
    • Intragumtornchai, Tanin;
    • Lamy, Thierry;
    • Dartigues, Peggy;
    • Francis Seymour, John;
    • Salles, Gilles
    Publication type:
    Article
    28

    Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 4, p. 410, doi. 10.1002/ajh.24305
    By:
    • Bachy, Emmanuel;
    • Estell, Jane A.;
    • Van de Neste, Eric;
    • Bouabdallah, Réda;
    • Bargay, Joan;
    • Delmer, Alain;
    • Gelas-Dore, Bénédicte;
    • da Silva, Maria Gomes;
    • Fitoussi, Olivier;
    • Belada, David;
    • Maisonneuve, Hervé;
    • Intragumtornchai, Tanin;
    • Lamy, Thierry;
    • Dartigues, Peggy;
    • Seymour, John Francis;
    • Salles, Gilles
    Publication type:
    Article
    29
    30
    31

    Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0322-5
    By:
    • Bobée, Victor;
    • Drieux, Fanny;
    • Marchand, Vinciane;
    • Sater, Vincent;
    • Veresezan, Liana;
    • Picquenot, Jean-Michel;
    • Viailly, Pierre-Julien;
    • Lanic, Marie-Delphine;
    • Viennot, Mathieu;
    • Bohers, Elodie;
    • Oberic, Lucie;
    • Copie-Bergman, Christiane;
    • Molina, Thierry Jo;
    • Gaulard, Philippe;
    • Haioun, Corinne;
    • Salles, Gilles;
    • Tilly, Hervé;
    • Jardin, Fabrice;
    • Ruminy, Philippe
    Publication type:
    Article
    32

    Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients.

    Published in:
    Frontiers in Microbiology, 2019, p. 1, doi. 10.3389/fmicb.2019.01898
    By:
    • Bal, Antonin;
    • Oriol, Guy;
    • Josset, Laurence;
    • Generenaz, Laurence;
    • Sarkozy, Clémentine;
    • Sesques, Pierre;
    • Salles, Gilles;
    • Morfin, Florence;
    • Lina, Bruno;
    • Becker, Jérémie;
    • Reynier, Frédéric;
    • Mallet, François;
    • Pachot, Alexandre;
    • Cheynet, Valérie;
    • Brengel-Pesce, Karen;
    • Trouillet-Assant, Sophie
    Publication type:
    Article
    33
    34
    35
    36

    Maintenance Therapy with a Monthly Injection of Alemtuzumab Prolongs Response Duration in Patients with Refractory B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (B-CLL/SLL).

    Published in:
    Leukemia & Lymphoma, 2004, v. 45, n. 4, p. 711, doi. 10.1080/10428190310001615675
    By:
    • Thieblemont, Catherine;
    • Bouafia, Fadhela;
    • Hornez, Emmanuel;
    • Dumontet, Charles;
    • Tartas, Sophie;
    • Antal, Daciana;
    • Lemieux, Bernard;
    • Traulle, Catherine;
    • Espinouse, Daniel;
    • Salles, Gilles;
    • Coiffier, Bertrand
    Publication type:
    Article
    37
    38
    39
    40

    Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

    Published in:
    Nature Genetics, 1999, v. 22, n. 1, p. 63, doi. 10.1038/8767
    By:
    • Zhang, Quangeng;
    • Siebert, Reiner;
    • Yan, Minhong;
    • Hinzmann, Bernd;
    • Cui, Xiaoli;
    • Xue, Liquan;
    • Rakestraw, Karen M.;
    • Naeve, Clayton W.;
    • Beckmann, Georg;
    • Weisenburger, Dennis D.;
    • Sanger, Warren G.;
    • Nowotny, Hadwiga;
    • Vesely, Michael;
    • Callet-Bauchu, Evelyne;
    • Salles, Gilles;
    • Dixit, Vishva M.;
    • Rosenthal, André;
    • Schlegelberger, Brigitte;
    • Morris, Stephan W.
    Publication type:
    Article
    41
    42
    43

    PB2304: FIVE‐YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L‐MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975944.73895.05
    By:
    • Duell, Johannes;
    • Abrisqueta, Pau;
    • Dreyling, Martin;
    • Gaidano, Gianluca;
    • Barca, Eva González;
    • Jurczak, Wojciech;
    • Liberati, Anna Marina;
    • Maddocks, Kami;
    • Menne, Tobias;
    • Nagy, Zsolt;
    • Tournilhac, Olivier;
    • Bakuli, Abhishek;
    • Amin, Aasim;
    • Gurbanov, Konstantin;
    • Salles, Gilles
    Publication type:
    Article
    44
    45
    46
    47
    48

    Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

    Published in:
    HemaSphere, 2023, v. 7, n. 4, p. e863, doi. 10.1097/HS9.0000000000000863
    By:
    • Stevens, Wendy B. C.;
    • Los‐de Vries, G. Tjitske;
    • Langois‐Jacques, Carole;
    • Clear, Andrew J.;
    • Stathi, Phylicia;
    • Sander, Birgitta;
    • Rosenwald, Andreas;
    • Calaminici, Maria;
    • Hoster, Eva;
    • Hiddemann, Wolfgang;
    • Gaulard, Philippe;
    • Salles, Gilles;
    • Klapper, Wolfram;
    • Xerri, Luc;
    • Burton, Catherine;
    • Tooze, Reuben M.;
    • Smith, Alexandra G.;
    • Buske, Christian;
    • Scott, David W.;
    • Natkunam, Yasodha
    Publication type:
    Article
    49

    A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD‐FL).

    Published in:
    HemaSphere, 2022, v. 6, n. 7, p. e745, doi. 10.1097/HS9.0000000000000745
    By:
    • Salles, Gilles;
    • Schuster, Stephen J.;
    • Fischer, Luca;
    • Kuruvilla, John;
    • Patten, Piers E. M.;
    • von Tresckow, Bastian;
    • Smith, Sonali;
    • Jiménez‐Ubieto, Ana;
    • Davis, Keith L.;
    • Nagar, Saurabh;
    • Zhang, Jie;
    • Bollu, Vamsi;
    • Jousseaume, Etienne;
    • Ramos, Roberto;
    • Wang, Yucai;
    • Link, Brian K.
    Publication type:
    Article
    50